Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 14Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 5Thyroid Neoplasms 4Stomach Neoplasms 4Salivary Gland Neoplasms 4Neoplasms 4Nasopharyngeal Neoplasms 4Esophageal Neoplasms 4Radiation Injuries 3Neoplasm Metastasis 3Melanoma 3Esthesioneuroblastoma, Olfactory 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Thyroid Carcinoma, Anaplastic 2Pharyngeal Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Mouth Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Merkel Cell 2Carcinoma 2

Interventions

Cisplatin 41Gemcitabine 25Radiotherapy, Intensity-Modulated 15Fluorouracil 15Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5spartalizumab 4Surveys and Questionnaires 4Bevacizumab 4toripalimab 3camrelizumab 3Nivolumab 3Induction Chemotherapy 3Immunohistochemistry 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Bevacizumab × Head & Neck × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT05305131 2025-09-23

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

National University Hospital, Singapore

Phase 2 Recruiting
50 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT03813394 2024-11-22

2018/00947

National University Hospital, Singapore

Phase 1/2 Active not recruiting
48 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT02250599 2015-12-30

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
80 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡